I-Fucoxanthin yinto engokwemvelo ethi ukunikeza izinhlobonhlobo zezinzuzo zezempilo. Etholakala emanzini asolwandle ayenziwe njengama-wakame ( Undaria pinnatifida ) ne-hijiki (i- Hijikia fusiformis ), kubhekwe njenge-carotenoid (okungukuthi, isigaba sezingulube zezitshalo ezinomphumela we- antioxidant ). I-Fucoxanthin iyatholakala futhi kwifomu lokuxhaswa kokudla, futhi ivame ukudayiswa njengesisindo sokulahlekelwa kwesisindo semvelo.
Ukusetshenziswa
Abagqugquzeli bakhombisa ukuthi i-fucoxanthin ingakwazi ukusekela ukulahlekelwa isisindo ngokusheshisa umzimba wakho nokukhuthaza ikhono lomzimba wakho ukushisa amafutha. I-Fucoxanthin iphindwe futhi njengendlela yokwelapha yemvelo yezindaba ezilandelayo zezempilo: isifo sikashukela, isifo senhliziyo, ukucindezeleka kwegazi, i-cholesterol ephakeme, isifo se-metabolic, nokukhuluphala.
Ngaphezu kwalokho, kuthiwa i-fucoxanthin ilwa nomdlavuza, futhi igcina impilo yesibindi.
Izinzuzo zezeMpilo
Olunye ucwaningo lwesandulela luveza ukuthi i-fucoxanthin ingaba nemiphumela eminingi yokuthuthukisa impilo. Isibonelo, kunobunye ubufakazi bokuthi i-fucoxanthin inganciphisa ukuvuvukala, kanye nokugqugquzela ukusebenza okunempilo kwesibindi, imithwalo yegazi, ubuchopho, amathambo, isikhumba, namehlo.
I-Fucoxanthin ibonakala ikhuthaza ukukhiqizwa kwe-docosahexaenoic acid (DHA). Uhlobo lwe- omega-3 fatty acid , i-DHA litholakale ukuvikela ngezinkinga zezempilo, kuhlanganise ne-arthritis, i-atherosclerosis, nokucindezeleka.
Nakuba okwamanje kunesifo sokuhlolwa kokuhlolwa kwemitholampilo ekuhloleni izinzuzo zezempilo ezingase zibe khona kubantu, izifundo zokuqala zibonisa ukuthi i-fucoxanthin ingase iphumelele ezimweni ezithile zempilo. Lezi zimo zihlanganisa:
1) Ukukhuluphala
I-Fucoxanthin ibonisa isithembiso ekwelapheni nasekuvimbelweni kokukhuluphala, ngokusho kokubuyekezwa kocwaningo okushicilelwe ku- Nutrition, Metabolism, ne-Cardiovascular Diseases ngo-2015.
Ekuhlaziyweni kwabo kocwaningo olushicilelwe ngaphambili, abalobi bokubukeza bathole ukuthi i-fucoxanthin ingalwela ukukhuluphala ngezindlela eziningi. Isibonelo, izifundo ezibuyekeziwe ziqaphele ukuthi i-fucoxanthin ingavimbela ukwakhiwa kwamafutha esiswini bese unciphisa amafutha omzimba esibindi. Kukhona nobufakazi bokuthi i-fucoxanthin ingathinta amazinga omzimba we-leptin (i-hormone ebalulekile ekulawuleni indlala).
2) Isifo sikashukela
Isifundo sezilwane eshicilelwe kwi- Molecular Medicine Reports ngo-2009 sathola ukuthi i-fucoxanthin ingasiza ekulawuleni isifo sikashukela. Esicwaningweni, ukuhlolwa kwamagundane kubonisa ukuthi i-fucoxanthin ingasiza ekulawuleni ushukela wegazi kanye nokwelapha ukumelana ne-insulin.
3) Cholesterol ephezulu
Olunye ucwaningo olusekelwe ezilwaneni lubonisa ukuthi i-fucoxanthin ingasiza ngokulawulwa kwe-cholesterol. Esifundweni esisekelwe egundini eshicilelwe ku- Biotechnology Journal ngo-2010, isibonelo, abacwaningi bathi ukuphathwa nge-fucoxanthin kwasiza amazinga e-cholesterol aphansi ezilwaneni ezondla ukudla okunamafutha aphezulu. Ucwaningo luphinde lwathola ukuthi i-fucoxanthin ingasiza ukukhulisa amazinga we-HDL ("okuhle") i-cholesterol.
Okuhlobene: Izixazululo ze-Cholesterol ephezulu
4) Igciwane
Esifundweni sokuqala emigqeni yamaselula, ososayensi baye baqaphela ukuthi i-fucoxanthin ingase ibe nezindawo zokulwa nomdlavuza.
Lezi zifundo zihlanganisa umbiko oshicilelwe ku- Anticancer Research ngo-2015, owathola ukuthi ukwelashwa nge-fucoxanthin kungasiza ekuvimbeleni ukwanda kwamangqamuzana omdlavuza webele.
Kubonakala sengathi i-fucoxanthin ingase igweme ukukhula komdlavuza ngokuyingxenye ngokunciphisa i-apoptosis (uhlobo oluthile lwesilingo sokufa olubalulekile ekuvimbeleni ukwanda kwamangqamuzana omdlavuza), kanye nokusebenza njenge-anti-angiogenesic agent (uhlobo lwezinto ezigcina ukukhula emisha yegazi entsha).
Imiphumela emibi nokuphepha Ukukhathazeka
Njengoba okwamanje kuntuleka kokuhlola ukuhlola imiphumela ye-fucoxanthin kubantu, okuncane kuyaziwa ngokuphepha kokusetshenziswa isikhathi eside noma okujwayelekile kwemikhiqizo ye-fucoxanthin.
Ukusebenzisa iFucoxanthin
Ngenxa yokungabi nesekelo lwesayensi yezinzuzo zezempilo ze-fucoxanthin, sekushesha kakhulu ukutusa ukusetshenziswa kwe-fucoxanthin izithako kunoma iyiphi injongo ephathelene nempilo.
Ungakwazi ukwandisa ukudla kwakho kwe-fucoxanthin ngokungeza i-wakame ne-hijiki kuya isobho, ukugubha, nama-saladi. Kodwa-ke, akunakwenzeka ukuthi ukudla okudliwayo kwe-fucoxanthin kuzoveza noma yimiphi imiphumela ebalulekile yempilo. Ngaphezu kwalokho, ukudla okuningi kwezilwandle kungabangela ubuthi be-iodine futhi kuphazamise umsebenzi wegciwane lakho le-thyroid.
Uma ucabangela ukusebenzisa ama-fucoxanthin supplements, khuluma nodokotela wakho ngaphambi kokuqala uhlelo lwakho lokwengeza.
Imithombo
I-Gammone MA, D'Orazio N. "Umsebenzi wokulwa nokukhuluphala komzimba we-carotenoid fucoxanthin." Izidakamizwa zikaMar. 2015 Apr 13; 13 (4): 2196-214.
Jeon SM, Kim HJ, Woo MN, Lee MK, Shin YC, Park YB, Choi MS. "I-fucoxanthin-rich richeswewe extract exduces body weight gain and improves metabolism lipid kuma-C57BL / 6J amagundane aphakeme kakhulu." I-Biotechnol J. 2010 Sep; 5 (9): 961-9.
Kim SK, i-Pangestuti R. "Imisebenzi yezinto eziphilayo kanye nezinzuzo zezempilo ezingokoqobo ze-fucoxanthin ezivela ezilwandle ezinosundu olwandle." I-Adv Food Nutr Res. 2011; 64: 111-28.
Maeda H, Hosokawa M, Sashima T, Murakami-Funayama K, Miyashita K. "Ukulwa nokukhuluphala nokuvimbela isifo sikashukela se-fucoxanthin ezimweni zokukhuluphala okubangelwa ukudla ngokweqile." I-Mol Med Rep. 2009 I-Nov-Dec; 2 (6): 897-902.
Maeda H, Hosokawa M, Sashima T, Takahashi N, Kawada T, Miyashita K. "I-Fucoxanthin ne-metabolite yayo, i-fucoxanthinol, igcizelela ukuhlukaniswa kwe-adipocyte kuma-3T3-L1 amangqamuzana." I-Int J Mol Med. 2006 Jul; 18 (1): 147-52.
Maeda H, Tsukui T, Sashima T, Hosokawa M, Miyashita K. "I-carotenoid yolwandle, i-fucoxanthin, njengezakhi eziningi ezisebenzayo." I-Asia Pac J Clin Nutriti. 2008; 17 Suppl 1: 196-9.
Martin LJ. "I-Fucoxanthin kanye ne-Metabolite Fucoxanthinol e-Cancer Prevention and Treatment." Izidakamizwa zikaMar. 2015 Jul 31; 13 (8): 4784-98.
Umradian Kh, Vaiserman A2, Min KJ3, Fraifeld VE4. "I-Fucoxanthin ne-lipid metabolism: I-minireview." I-Nutr Metab I-Cardiovasc Dis. 2015 Okthoba; 25 (10): 891-7.
Peng J, Yuan JP, Wu CF, Wang JH. "I-Fucoxanthin, i-carotenoid yasolwandle ekhona emanzini amaningi asolwandle nama-diatoms: i-metabolism kanye nama-bioactivities ahlobene nempilo yabantu." Izidakamizwa zikaMar. 2011; 9 (10): 1806-28.
I-Rengarajan T, Rajendran P, uNandakumar N, MP MP yeBalasubramanian, uNishigaki I. "Ukuphumelela kwegciwane lokuvimbela umdlavuza we-carotenoid fucoxanthin: ukuboshwa kwamaseli kanye nokupoptosis." Amakhemikhali. 2013 Dec 6; 5 (12): 4978-89.
Rwigemera A, Mamelona J1, Martin LJ2. "Imiphumela yokuqhathanisa phakathi kwe-fucoxanthinol ne-precursor fucoxanthin ekusebenzeni nase-apoptosis yemigqa yesifo somdlavuza wesifuba i-MCF-7 ne-MDA-MB-231." I-Anticancer Res. 2015 Jan; 35 (1): 207-19.
Wang L, Zing Y, Liu Y, Hu X, Li S, Wang Y, Li L, Lei Z, Zhang Z. "I-Fucoxanthin ikhuthaza ukuboshwa ukukhulelwa kanye ne-apoptosis emdlalweni womuntu wesifo se-T24 amaseli ngoku-uphawulo we-p21 ne-down-regulation of mortalin. " I-Acta Biochim Biophys Sin (Shanghai). 2014 Oct; 46 (10): 877-84.
Woo MN, Jeon SM, Shin YC, Lee MK, Kang MA, Choi MS. "Impahla e-Anti-obese ye-fucoxanthin iyingxenye ye-enzyme elawula i-lipid futhi ihlukanisa amaprotheni we-visceral adipose tissue kumagundane." I-Mol Nutr Food Res. 2009 Dec; 53 (12): 1603-11.
Zheng J, Piao MJ, Kim KC, Yao CW, Cha JW, Hyun JW. "I-Fucoxanthin ikhulisa izinga le-glutathione elincishisiwe ngendlela ye-Nrf2-mediated in keratinocytes yabantu." Izidakamizwa zikaMar. 2014 Jul 15; 12 (7): 4214-30.
Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela olayisensi. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.